Statins are independently associated with increased HbA1c in type 1 diabetes - The Thousand & 1 Study

Diabetes Research and Clinical Practice

Volumn 111, Issue , 2016, Pages 51-57

  Jensen, Magnus Thorsten ^a,b,c   Andersen, Henrik Ullits ^c   Rossing, Peter ^c,e,f   Jensen, Jan Skov ^b,d  

^a HOLBÆK HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c STENO DIABETES CENTER   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e Capital Region   (Denmark)

^f AARHUS UNIVERSITY   (Denmark)

Author keywords

Diabetes; Glycemic control; HbA1c; Prevention; Statins; Type 1 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ADULT; AGE; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DENMARK; DISEASE DURATION; FAMILY HISTORY; FEMALE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; RETINOPATHY; SEX DIFFERENCE; SMOKING; AGED; ANALYSIS; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; ECHOCARDIOGRAPHY; ECHOGRAPHY; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE FUNCTION; HYPERCHOLESTEROLEMIA; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DENMARK; DIABETES MELLITUS, TYPE 1; ECHOCARDIOGRAPHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INSULIN; MALE; MIDDLE AGED; VENTRICULAR FUNCTION, LEFT;

EID: 84957428113     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.10.022     Document Type: Article

References (24)

1. Carter A.A., Gomes T., Camacho X., Juurlink D.N., Shah B.R., Mamdani M.M. Risk of incident diabetes among patients treated with statins: population based study. BMJ 2013, 346:f2610. 10.1136/bmj.f2610.
2. Preiss D., Sattar N. Statins and the risk of new-onset diabetes: a review of recent evidence. Curr Opin Lipidol 2011, 22:460-466. 10.1097/MOL.0b013e32834b4994.
3. Sattar N., Preiss D., Murray H.M., Welsh P., Buckley B.M., de Craen A.J., et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 2010, 375:735-742. 10.1016/S0140-6736(09)61965-6.
4. Collins R., Armitage J., Parish S., Sleigh P., Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003, 361:2005-2016.
5. Preiss D., Seshasai S.R.K., Welsh P., Murphy S.A., Ho J.E., Waters D.D., et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA 2011, 305:2556-2564. 10.1001/jama.2011.860.
6. Cederberg H., Stančáková A., Yaluri N., Modi S., Kuusisto J., Laakso M. Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort. Diabetologia 2015, 10.1007/s00125-015-3528-5.
7. Nakata M., Nagasaka S., Kusaka I., Matsuoka H., Ishibashi S., Yada T. Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control. Diabetologia 2006, 49:1881-1892. 10.1007/s00125-006-0269-5.
8. Konduracka E., Galicka-Latala D., Cieslik G., Rostoff P., Fedak D., Sieradzki J., et al. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension. Diabetes Obes Metab 2008, 10:719-725. 10.1111/j.1463-1326.2007.00798.x.
9. Jensen M.T., Sogaard P., Andersen H.U., Bech J., Hansen T.F., Galatius S., et al. Prevalence of systolic and diastolic dysfunction in patients with type 1 diabetes without known heart disease: the Thousand & 1 Study. Diabetologia 2014, 10.1007/s00125-014-3164-5.
10. Jensen M.T., Sogaard P., Andersen H.U., Bech J., Fritz Hansen T., Biering-Sorensen T., et al. Global longitudinal strain is not impaired in type 1 diabetes patients without albuminuria: The Thousand & 1 Study. JACC Cardiovasc Imaging 2015, 10.1016/j.jcmg.2014.12.020.
11. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 2005, 18:1440-1463. 10.1016/j.echo.2005.10.005.
12. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
13. Erqou S., Lee C.C., Adler A.I. Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis. Diabetologia 2014, 57:2444-2452. 10.1007/s00125-014-3374-x.
14. Tajima N., Kurata H., Nakaya N., Mizuno K., Ohashi Y., Kushiro T., et al. Pravastatin reduces the risk for cardiovascular disease in Japanese hypercholesterolemic patients with impaired fasting glucose or diabetes: diabetes subanalysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study. Atherosclerosis 2008, 199:455-462. 10.1016/j.atherosclerosis.2008.05.027.
15. Waters D.D., Ho J.E., DeMicco D.A., Breazna A., Arsenault B.J., Wun C.C., et al. Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. J Am Coll Cardiol 2011, 57:1535-1545. 10.1016/j.jacc.2010.10.047.
16. Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto A.M., Kastelein J.J., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med Online 2008, 10.1056/NEJMoa0807646.
17. Orchard T.J., Nathan D.M., Zinman B., Cleary P., Brillon D., Backlund J.Y., et al. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA 2015, 313:45-53. Writing Group for the DCCT/EDIC Research Group. 10.1001/jama.2014.16107.
18. Nilsson P.M., Gudbjörnsdottir S., Eliasson B., Cederholm J. Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes - data from the National Diabetes Register in Sweden. Diabetes Metab 2004, 30:261-268. Steering Committee of the Swedish National Diabetes Register.
19. Madsbad S., McNair P., Christensen M.S., Christiansen C., Faber O.K., Binder C., et al. Influence of smoking on insulin requirement and metabolic status in diabetes mellitus. Diabetes Care 1980, 3:41-43.
20. Bangstad H.-J., Østerby R., Rudberg S., Hartmann A., Brabrand K., Hanssen K.F., et al. Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria. Diabetologia 2002, 45:253-261. 10.1007/s00125-001-0744-y.
21. Bott U., Jörgens V., Grüsser M., Bender R., Mühlhauser I., Berger M. Predictors of glycaemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme. Diabet Med J Br Diabet Assoc 1994, 11:362-371.
22. Sukhija R., Prayaga S., Marashdeh M., Bursac Z., Kakar P., Bansal D., et al. Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients. J Investig Med Off Publ Am Fed Clin Res 2009, 57:495-499. 10.231/JIM.0b013e318197ec8b.
23. Ridker P.M., Pradhan A., MacFadyen J.G., MacFadyen J.G., Libby P., Glynn R.J. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet 2012, 380:565-571. 10.1016/S0140-6736(12)61190-8.
24. Shah R.V., Goldfine A.B. Statins and risk of new-onset diabetes mellitus. Circulation 2012, 126:e282-e284. 10.1161/CIRCULATIONAHA.112.122135.